Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03322046 · ClinicalTrials.gov registry record
Heartmatters Challenge - First Responders
A clinical trial of Cardiovascular Diseases, sponsored by Boston Heart Diagnostics.
- Completed
- Registry status
- 185
- Enrollment target
- 1
- Study location
NCT03322046: Completed study of Cardiovascular Diseases, sponsored by Boston Heart Diagnostics.
NCT03322046 is a study of Cardiovascular Diseases that has completed, run by Boston Heart Diagnostics. The registered enrollment target is 185 participants, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03322046, a study of Cardiovascular Diseases, has completed, sponsored by Boston Heart Diagnostics.
- COMPLETED
- Registry status
- 185 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this protocol is to observe whether providing the first responder population with a multi-tiered therapeutic lifestyle modification program, including regular blood testing, diet and telephonic lifestyle coaching, daily food journaling using web-based tools and smartphone apps can lead to positive changes in behavior, resulting in improvements in blood based markers of risk of cardiovascular disease (CVD) as well as improvements in weight and waist circumference.
Primary Outcome
Change in weight from baseline measurement
Conditions Studied
Interventions
- BEHAVIORAL Lifestyle Program
Study Locations (1)
Massachusetts
- Boston Heart Diagnostics - Framingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 185 participants |
| Start Date | 2013-10-08 |
| Est. Completion | 2015-01-08 |
What the finished NCT03322046 record still lists
NCT03322046 is an observational study that tracks outcomes without assigning an intervention. The registered 185 participants enrollment target is mid-sized for trials with a published cap, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Cardiovascular Diseases appearing as the primary indexed condition, and to 1 intervention - of which Lifestyle Program is the first listed.
NCT03322046 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03322046 about?
NCT03322046 is a clinical study titled "Heartmatters Challenge - First Responders". The purpose of this protocol is to observe whether providing the first responder population with a multi-tiered therapeutic lifestyle modification program, including regular blood testing, diet and telephonic lifestyle coaching, daily food journaling using web-based tools and smartphone apps can lea...
What is the current status of trial NCT03322046?
This trial is currently completed. The enrollment target is 185 participants. The study started on 2013-10-08. Estimated completion is 2015-01-08.
What conditions does trial NCT03322046 study?
This clinical trial studies the following conditions: Cardiovascular Diseases.
What interventions are being tested in trial NCT03322046?
The interventions under investigation include: Lifestyle Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT03322046?
This trial is sponsored by Boston Heart Diagnostics, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03322046 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03322046's enrollment target sits among peer trials
185 157th of 300 higher than 144 of 300 other Cardiovascular Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiovascular Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes
RECRUITING · Phase 1
-
The Influence of Chardonnay Marc Intake on Gut and Cardiometabolic Health
RECRUITING · NA
-
TRANSCRIBE (Transcriptomic Analysis of Left Ventricular Gene Expression)
RECRUITING
-
Identifying Strategies to Reduce Cardiovascular Risk Among Mothers of Young Children
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04041154 · 185 participants · NA
Behavioral and Neural Representations of Subjective Effort Cost
- NCT04484272 · 185 participants · NA
A Stress and Pain Self-management m-Health App for Adult Outpatients With Sickle Cell Disease
- NCT05020860 · 185 participants · Phase 2
Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer
- NCT05793541 · 185 participants · NA
Just-in-time Interventions for Reducing Short-term Suicide Risk
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI